Capmatinib Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01546428A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors